舒血宁+维生素C+普罗碘胺+和血明目片治疗外伤性及糖尿病性视网膜病变玻璃体积血58例临床观察  

Clinical Observation of Treatment of 58 Cases of Vitreous Hemorrhage Caused by Traumatic and Diabetic Retinopathy Throught Applyjing Shuxuening + Vitamin C + Prolonium Iodide and Hexuemingmupian

作　　者：田岩[1,2] 朱宁云[3] 张方顺[1] 李庆华 

机构地区：[1]辽宁中医药大学第一临床学院 [2]抚顺市第三医院眼科,辽宁抚顺113004 [3]辽宁中医药大学第一附属医院眼科,沈阳110032 [4]抚顺市眼科医院中检科,辽宁抚顺113008

出　　处：《实用中医内科杂志》2015年第6期91-92,共2页Journal of Practical Traditional Chinese Internal Medicine

摘　　要：[目的]观察舒血宁＋维生素C＋普罗碘胺＋和血明目片治疗外伤性及糖尿病性视网膜病变玻璃体积血疗效。[方法]使用前瞻性设计方法，58例住院患者卧床休息；舒血宁20mL＋0.9%氯化钠250mL，1次/d，静滴；维生素C 2.5＋0.9%氯化钠250mL，1次/d，静滴；普罗碘胺2mL，1次/d，肌注；和血明目片，5片/次，3次/d；糖尿病降糖，空腹血糖控制6-9mmol/L，糖化血红蛋白5%-8%。合并高血压、高血脂等控制血压、血脂等。连续治疗6周为1疗程。观测临床症状、不良反应。治疗1疗程，判定疗效。[结果]治愈33例，好转23例，无效2例，总有效率96.56%。[结论]舒血宁＋维生素C＋普罗碘胺＋和血明目片治疗外伤性及糖尿病性视网膜病变玻璃体积血，疗效满意，无严重不良反应，值得推广。[Objective] To observe effect of treatment of applyjing Shuxuening ＋ Vitamin C ＋ Prolonium Iodide and Hexuemingmupian for vitreous hemorrhage caused by traumatic and diabetic retinopathy.[Methods] Using a prospective design method, 58 cases of hospitalized patients with bed rest; Shuxuening 20 m L ＋ 0.9% sodium chloride 250 m L, 1 times/d, intravenous infusion; vitamin C 2.5 ＋ 0.9% sodium chloride 250 m L, 1 times/d, intravenous infusion; prolonium 2m L, 1 times/d, intramuscular injection; and hexuemingmupian, 5/time, 3 times/d; diabetes glucose, fasting blood glucose： 6-9mmol/L, hemoglobin ：5 % to 8%. Hypertension, high cholesterol and other control blood pressure, blood lipids. Continuous treatment for six weeks for a course. To observe clinical symptoms, adverse reactions. After a course of treatment to determine efficacy.[Results] 33 cases were cured, improved in 23 cases and 2 cases were Invalid. The total efficiency is 96.56%.[Discussions] Applying Shuxuening ＋ Vitamin C ＋ Prolonium Iodide and Hexuemingmupian to treat vitreous hemorrhage caused by traumatic and diabetic retinopathy, Results were satisfactory, no serious adverse reactions. It is worth promoting.

关 键 词：玻璃体积血 暴盲 外伤性 糖尿病性视网膜病变 舒血宁 维生素C 普罗碘胺 和血明目片 中西医结合治疗 前瞻性设计 

分 类 号：R587.2[医药卫生—内分泌]